HealthEquity (NASDAQ:HQY) Stock Price Expected to Rise, JMP Securities Analyst Says

HealthEquity (NASDAQ:HQY - Free Report) had its price target boosted by JMP Securities from $110.00 to $117.00 in a report published on Wednesday, MarketBeat reports. They currently have a market outperform rating on the stock.

Other equities analysts also recently issued reports about the company. The Goldman Sachs Group lowered their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. KeyCorp cut their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Bank of America raised their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Barrington Research restated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, April 11th. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of "Buy" and a consensus target price of $118.09.

HealthEquity Stock Down 0.3%

Shares of HQY stock traded down $0.36 during mid-day trading on Wednesday, reaching $112.70. 1,948,931 shares of the company's stock traded hands, compared to its average volume of 823,847. HealthEquity has a 12 month low of $65.01 and a 12 month high of $116.69. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $9.75 billion, a P/E ratio of 103.39, a P/E/G ratio of 1.60 and a beta of 0.45. The company's 50-day moving average price is $90.51 and its 200-day moving average price is $97.67.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. The business had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. During the same quarter last year, the company earned $0.80 EPS. On average, equities analysts expect that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company's stock.

Institutional Trading of HealthEquity

Hedge funds have recently bought and sold shares of the stock. Inspire Investing LLC raised its position in shares of HealthEquity by 8.6% in the 1st quarter. Inspire Investing LLC now owns 7,529 shares of the company's stock worth $665,000 after acquiring an additional 597 shares in the last quarter. Hodges Capital Management Inc. purchased a new stake in HealthEquity during the first quarter valued at approximately $1,988,000. Strs Ohio purchased a new stake in HealthEquity during the first quarter valued at approximately $999,000. Mattson Financial Services LLC lifted its position in HealthEquity by 15.5% during the first quarter. Mattson Financial Services LLC now owns 1,988 shares of the company's stock valued at $176,000 after acquiring an additional 267 shares during the last quarter. Finally, Belpointe Asset Management LLC purchased a new stake in HealthEquity during the first quarter valued at approximately $756,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.